Andre I. Calin
#139,935
Most Influential Person Now
Andre I. Calin's AcademicInfluence.com Rankings
Andre I. Calinphilosophy Degrees
Philosophy
#7272
World Rank
#10461
Historical Rank
Logic
#4325
World Rank
#5600
Historical Rank
Andre I. Calinbiology Degrees
Biology
#9866
World Rank
#13121
Historical Rank
Genetics
#1019
World Rank
#1117
Historical Rank
Molecular Biology
#1379
World Rank
#1406
Historical Rank
Download Badge
Philosophy Biology
Why Is Andre I. Calin Influential?
(Suggest an Edit or Addition)Andre I. Calin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. (1994) (2911)
- The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. (1991) (2214)
- A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. (1994) (2056)
- Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. (1994) (972)
- Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. (2005) (677)
- Clinical history as a screening test for ankylosing spondylitis. (1977) (618)
- Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. (1997) (587)
- The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. (1998) (317)
- Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis (2004) (309)
- Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. (1999) (306)
- The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). (1996) (301)
- Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. (1975) (263)
- Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis (2000) (258)
- Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. (2001) (251)
- Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. (1997) (249)
- HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. (1996) (246)
- Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. (2001) (242)
- Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. (2005) (218)
- OSTEOPOROSIS IN EARLY ANKYLOSING SPONDYLITIS: A PRIMARY PATHOLOGICAL EVENT? (1989) (208)
- Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. (1981) (207)
- Rheumatology (1990) (204)
- Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? (1999) (192)
- A genome-wide screen for susceptibility loci in ankylosing spondylitis. (2004) (185)
- Predictors of longterm outcome in ankylosing spondylitis. (2003) (167)
- Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. (1999) (163)
- The natural history of ankylosing spondylitis as defined by radiological progression. (2002) (161)
- A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) (1995) (159)
- The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. (2004) (139)
- Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. (1996) (139)
- The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. (2004) (132)
- An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. (1976) (123)
- Reiter's syndrome. Evaluation of preliminary criteria for definite disease. (1981) (121)
- Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. (1990) (120)
- The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). (2004) (120)
- Is disease severity in ankylosing spondylitis genetically determined? (2001) (118)
- A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. (1999) (116)
- The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: a randomized controlled trial. (2002) (112)
- Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. (2001) (111)
- Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. (2001) (105)
- The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. (2000) (102)
- Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. (1999) (95)
- The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. (1979) (94)
- Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. (1989) (94)
- Role of NOD2 variants in spondylarthritis. (2002) (93)
- Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease. (1988) (93)
- Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. (2000) (93)
- Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. (1999) (91)
- Identification of major loci controlling clinical manifestations of ankylosing spondylitis. (2003) (90)
- Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. (2005) (87)
- Ankylosing spondylitis: the correlation between a new metrology score and radiology. (1995) (83)
- Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. (1983) (82)
- Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. (2001) (81)
- Fatigue in ankylosing spondylitis--why is it ignored? (1993) (81)
- Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. (1993) (77)
- Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. (1985) (76)
- Impact of sex on inheritance of ankylosing spondylitis: a cohort study (1999) (75)
- Pain and inflammation (1981) (72)
- Ankylosing spondylitis in women and men: a case-control study. (1983) (70)
- The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. (1996) (70)
- Exercise in ankylosing spondylitis: how much is optimum? (1998) (69)
- Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. (1982) (68)
- DRUG TREATMENT OF RHEUMATOID ARTHRITIS (1975) (65)
- Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. (1994) (62)
- Reiter's syndrome following epidemic shigellosis. (1981) (61)
- Bath Ankylosing Spondylitis Functional Index. (1995) (60)
- The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis--one disease process or several? (1988) (60)
- Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation. (1983) (58)
- The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study. (1983) (57)
- Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. (2002) (55)
- Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. (1998) (55)
- Definition of disease flare in ankylosing spondylitis: the patients' perspective. (2002) (54)
- Concordance of disease severity among family members with ankylosing spondylitis? (2004) (53)
- Seronegative spondyloarthritides. (1986) (52)
- Non-B27 MHC associations of ankylosing spondylitis (2007) (51)
- The X-chromosome and susceptibility to ankylosing spondylitis. (2000) (51)
- A case-control study of juvenile- and adult-onset ankylosing spondylitis. (1982) (50)
- Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. (1997) (49)
- Willingness to accept risk in the treatment of rheumatic disease. (1990) (48)
- The case against seronegative rheumatoid arthritis. (1981) (48)
- Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. (1997) (48)
- A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. (1989) (46)
- Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. (1999) (43)
- The natural history of juvenile-onset ankylosing spondylitis: a 24-year retrospective case-control study. (1988) (43)
- A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis. (1990) (42)
- The natural history of ankylosing spondylitis. Does it burn out? (1993) (41)
- Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. (1994) (38)
- The individual with ankylosing spondylitis: defining disease status and the impact of the illness. (1995) (38)
- Which patients with ankylosing spondylitis derive most benefit from an inpatient management program? (1997) (37)
- Excess deoxycorticosterone secretion from adrenocortical carcinoma. (1974) (37)
- Double-blind Cross-over Trial of Flurbiprofen and Phenylbutazone in Ankylosing Spondylitis (1974) (37)
- Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. (1991) (36)
- The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. (2003) (35)
- Intestinal perforation associated with osmotic slow release indomethacin capsules (1984) (35)
- A placebo controlled, crossover study of azathioprine in Reiter's syndrome. (1986) (34)
- An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. (1996) (34)
- Prevalence of spondyloarthritis in Terceira, Azores: a population based study (2002) (33)
- Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group (2003) (33)
- The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis. (2004) (32)
- Familial aggregation of Reiter's syndrome and ankylosing spondylitis: a comparative study. (1984) (32)
- Ankylosing spondylitis. (1985) (32)
- The outcome of 138 total hip replacements and 12 revisions in ankylosing spondylitis: high success rate after a mean followup of 7.5 years. (1989) (31)
- Familial versus sporadic ankylosing spondylitis. Two different diseases? (1993) (31)
- Juvenile onset ankylosing spondylitis--more girls than we thought? (1997) (29)
- A historical perspective of the spondyloarthritis (2011) (29)
- New light on uveitis in ankylosing spondylitis. (1991) (28)
- Reiter's syndrome: evaluation of proposed criteria. (1979) (28)
- Presence of circulating immune complexes in Reiter's syndrome and ankylosing spondylitis (1981) (26)
- Letter: Drug treatment of rheumatoid arthritis. (1975) (24)
- Reiter's syndrome. (1977) (24)
- Relative role of genetic and environmental factors in disease expression: sib pair analysis in ankylosing spondylitis. (1989) (24)
- Is there an association between ankylosing spondylitis and multiple sclerosis? (1989) (24)
- Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. (1979) (23)
- Bacterial endocarditis presenting as acute monoarthritis. (1988) (23)
- Selective IgA deficiency and spondyloarthropathy: a distinct disease? (1990) (23)
- Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. (1990) (21)
- The treatment of intractable rheumatoid arthritis with lymphoid irradiation. (1981) (21)
- Can we define the outcome of ankylosing spondylitis and the effect of physiotherapy management? (1994) (20)
- Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. (1990) (19)
- A comparison of the efficacy and tolerability of lornoxicam and indomethacin in ankylosing spondylitis (1992) (18)
- The natural history of ankylosing spondylitis: is the disease really changing? (1989) (18)
- Keratodermia blennorrhagica and mucocutaneous manifestations of Reiter's syndrome. (1979) (18)
- Ankylosing spondylitis and the shoulder: commonly involved but infrequently disabling. (2000) (18)
- Comment on article by van der Linden et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. (1985) (17)
- Prognosis and natural history of Reiter's syndrome. (1979) (17)
- Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003. (2004) (17)
- Late onset ankylosing spondylitis--a distinct disorder? (1991) (16)
- Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin. (1979) (16)
- The close correlation between symptoms and disease expression in HLA B27 positive individuals. (1977) (15)
- Raised serum creatine phosphokinase activity in ankylosing spondylitis. (1975) (15)
- HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al. (1996) (14)
- Osteoporosis and ankylosing spondylitis. (1991) (14)
- Royal National Hospital for Rheumatic Diseases--Bath. A 250th birthday party. (1988) (14)
- Porphyria cutanea tarda associated with methotrexate therapy. (1993) (13)
- Assessment of disease severity (in terms of function) using the internet. (2004) (13)
- Spondylodiscitis and pseudarthrosis in a patient with enteropathic spondyloarthropathy. (1991) (13)
- Cervical spine surgery in ankylosing spondylitis: Is the outcome good? (1997) (12)
- Ulcerogenicity of piroxicam: an analysis of spontaneously reported data (1987) (12)
- Arthritis in a patient with mycosis fungoides: complete remission after radiotherapy. (1979) (12)
- The Dunlop-Dottridge Lecture. Ankylosing spondylitis: defining disease status and the relationship between radiology, metrology, disease activity, function, and outcome. (1995) (12)
- The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis. (1998) (11)
- Efficacy and tolerance of a novel precision-dose formulation of indomethacin: double-blind trials in rheumatoid arthritis and osteoarthritis. (1983) (11)
- Issues in rheumatoid arthritis (1999) (11)
- Ankylosing spondylitis: Discussions in patient management (1978) (10)
- Renal glomerular function in ankylosing spondylitis. (1975) (10)
- Rarity of nephropathy in ankylosing spondylitis. (1982) (10)
- Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. (1977) (10)
- Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. (1974) (10)
- Birth order and ankylosing spondylitis: no increased risk of developing ankylosing spondylitis among first-born children. (2002) (10)
- Oligoarthropathy with chronic iridocyclitis--a disease only of childhood? (1982) (9)
- Therapeutic intervention in rheumatoid arthritis: a case-controlled comparison of seronegative and seropositive disease. (1988) (9)
- Pathogenesis of ankylosing spondylitis: the state of the art. (1988) (9)
- Ankylosing rheumatoid arthritis. (1975) (9)
- Rheumatoid arthritis: extra-articular manifestations. (1969) (9)
- Reiter's syndrome. (1977) (9)
- Treatment of ankylosing spondylitis with oxaprozin: A comparison with indomethacin (1986) (8)
- Increasing age at presentation for patients with ankylosing spondylitis. (1992) (8)
- Geode development and multiple fractures in rheumatoid arthritis. (1985) (7)
- Clinical Use of Tolmetin Sodium in Patients with Ankylosing Spondylitis: A Review (1983) (7)
- Bronchorrhoea. (1972) (7)
- Letter: Normal frequency of HL-A B27 in aortic insufficiency. (1976) (7)
- X-radiation in the management of rheumatoid disease. (1985) (7)
- Serum keratan sulphate levels rise in rheumatoid arthritis patients, but fall in ankylosing spondylitis patients compared with normal controls. (1990) (7)
- Maternal age and the risk of developing ankylosing spondylitis (1997) (7)
- Impact of sex on inheritance of ankylosing spondylitis (2000) (7)
- Retrospective analysis of 376 irradiated patients with ankylosing spondylitis and nonirradiated controls. (1989) (6)
- Workshop III. Management of Reiter's syndrome. (1979) (6)
- The natural history and prognosis of ankylosing spondylitis. (1988) (6)
- Overview: Focus on physician-patient communication (1986) (6)
- Postsalmonella reactive phenomena in 2 patients with ankylosing spondylitis: no modification of the underlying disease. (1990) (6)
- The epidemiology of rheumatoid disease: past and present. (1986) (6)
- The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? (1990) (6)
- Ankylosing spondylitis. Comparative analysis of Swedish (n = 780) and British (n = 1500) experience--the National Ankylosing Spondylitis Societies. (1987) (6)
- HLA-DRw4, RHEUMATOID FACTOR, AND PROGNOSIS IN RHEUMATOID ARTHRITIS (1979) (5)
- Diagnostic criteria (new and old) for the spondylarthropathies. (1987) (5)
- Analysis of HLA-B27 antigen with monoclonal antibodies. (1983) (5)
- Ankylosing spondylitis and epidemic Reiter's syndrome: genetics and environment [Proceedings]. (1976) (5)
- Management of ankylosing spondylitis. (1981) (5)
- Survival, alcohol and deaths in ankylosing spondylitis. (1998) (5)
- Defining outcome in ankylosing spondylitis. Where have we been, where are we and where do we go from here? (2002) (5)
- Diagnosis and management of rheumatoid arthritis (1983) (4)
- NO ADDITIONAL ROLE FOR THE MHC CLASS-II ENCODED COMPONENTS OF THE HLA CLASS-I PATHWAY OF ANTIGEN PRESENTATION (LMP2, TAP1-AND-2) IN THE ETIOLOGY OF ANKYLOSING-SPONDYLITIS (AS) (1993) (4)
- Therapeutic focus. Piroxicam. (1988) (4)
- What do patients and rheumatologists regard as an 'acceptable' risk in the treatment of rheumatic disease? (1991) (4)
- Spondyloarthropathy in Caucasians and non-Caucasians. (1983) (4)
- Comparison of erect and supine radiographs of the hip. (1987) (3)
- A controlled trial of ‘Froben’ (flurbiprofen) in ankylosing spondylitis—comparison with phenylbutazone (1975) (3)
- Ethnic differences in ankylosing spondylitis: disease expression in Pakistan compared to Britain. (1997) (3)
- On the reassessment of the prevalence of As among B27 positive normal individuals. (1980) (3)
- Multicentre Double-Blind Comparison of Sustained Action Formulations of Tiaprofenic Acid and Indomethacin in Osteoarthritis (2012) (3)
- Clinical aspects of the effect of NSAID on cartilage. (1989) (3)
- HLA–A28 in B27 Positive Controls and Patients with Ankylosing Spondylitis (1977) (3)
- Towards defining the genetic determinants of disease severity in ankylosing spondylitis. (2001) (3)
- Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. (1995) (2)
- Thehandradiograph asadiagnostic discriminant between seropositive andseronegative 'rheumatoid arthritis': acontrolled study (1983) (2)
- Adverse reactions to penicillamine after gold toxicity (1980) (2)
- The elusive triad. (1981) (2)
- HLA B27, the arthritogenic peptide, and the effector T cell (1993) (2)
- The spondylarthropathies: clinical aspects. (1987) (2)
- Summary: The next step (1986) (2)
- The single hot joint. (1976) (2)
- Confirmation of non-MHC genetic loci by whole genome linkage studies in ankylosing spondylitis. (2000) (1)
- A placebo controlled, crossoverstudy ofazathioprine inReiter's syndrome (1986) (1)
- Early detection of aortic root abnormalities in ankylosing spondylitis by two-dimensional echocardiography (1980) (1)
- Anti-TNF drugs in ankylosing spondylitis: the present and future (2008) (1)
- Ankylosing spondylitis and the other seronegative spondylarthritides. (1979) (1)
- Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. (1981) (1)
- Letter: HL-A antigens and ankylosing spondylitis. (1975) (1)
- Ankylosing spondylitis: genetics versus environment. (1976) (1)
- Ankylosing Spondylitis-Reply (1977) (1)
- United Kingdom . spondylitis in the white population in the HLA class I associations of ankylosing (1)
- Neutropenia and rheumatoid arthritis. (1978) (1)
- Lymphocyte proliferative responses to bacterial antigens in B27-associated arthropathies. (1985) (1)
- TRANSFORMING GROWTH FACTOR BETA-1 GENE POLYMORPHISMS AND ANKYLOSING SPONDYLITIS (2003) (1)
- Leadership role of the rheumatologist: toward reaching a consensus. (1988) (1)
- EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS (1977) (1)
- Hip involvement in ankylosing spondylitis and poor function but successful outcome with early total hip replacement (2010) (0)
- MHC class II and III genes are associated with ankylosing spondylitis independent of HLA-B27. (2004) (0)
- spondylitis among first-born children. Birth order and ankylosing spondylitis: no increased risk of developing ankylosing (2004) (0)
- Back pain--what can we offer? (1979) (0)
- Increasing age atpresentation forpatients with ankylosing spondylitis (1992) (0)
- Commentary (1966) (0)
- HLA class Iassociations ofankylosing spondylitis inthewhite population intheUnited Kingdom (1996) (0)
- REITER'S SYNDROME (1979) (0)
- Immunology: a facet of aging. (1977) (0)
- Drugs and the relationships between university, industry and legislation. (1987) (0)
- Prognosis andnatural history ofReiter's syndrome (1979) (0)
- Differentiating rheumatoid arthritis from other arthropathies. (1990) (0)
- ankylosing Spondylitis - a Major advance in Management : Light at the e nd of the p roverbial t unnel (2005) (0)
- Differential diagnosis in rheumatology : an atlas for the physician (1984) (0)
- Rheumatoid arthritis. (1978) (0)
- Classification of seronegative arthritis: Recent developments (1983) (0)
- P16. Marked osteoporosis is present in early ankylosing spondylitis and progresses in late disease (1990) (0)
- A post World War II date of birth peak in patients subsequently developing AS is unexplained. (1990) (0)
- How important is physiotherapy in the treatment of ankylosing spondylitis (2004) (0)
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND JOINT EROSIONS (1981) (0)
- Back pain--what can we offer? (1979) (0)
- Reiter's syndrome. Evaluation of preliminary criteria for definite disease. (1982) (0)
- MYCOPHENOLATE MOFETIL: A POTENTIAL TREATMENT FOR REDUCING PROTEINURIA ASSOCIATED WITH MEMBRANOUS LUPUS NEPHRITIS (2003) (0)
- The monitoring of patients on disease-modifying antirheumatoid drugs. (1993) (0)
- A pair of radiologic 'red herrings'. (1981) (0)
- Total hip arthroplasty in ankylosing spondylitis [1] (multiple letters) (2002) (0)
- Distributing association-approved educational literature (1986) (0)
- "LEPROMATOUS" AND "TUBERCULOID" RHEUMATOID ARTHRITIS (1982) (0)
- Celecoxib and ankylosing spondylitis (2008) (0)
- The role of B*60 in disease expression of ankylosing spondylitis. (1997) (0)
- The IL1 gene cluster is a major locus determining susceptibility to Ankylosing spondylitis. (2003) (0)
- Therapeutic focus (1988) (0)
- Reactive arthritis. (1980) (0)
- Advances in the Management of Ankylosing Spondylitis (2013) (0)
- Mapping of MHC class II and III genes associated with Ankylosing spondylitis independent of HLA-B27 (2005) (0)
- HLA-B27, rheumatoid factor and spondyloarthritis. (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andre I. Calin?
Andre I. Calin is affiliated with the following schools:
